Peptide Research Overview
CJC-1295 with DAC is a modified growth hormone releasing hormone (GHRH) analogue peptide incorporating Drug Affinity Complex (DAC) technology for extended half-life characteristics. As a synthetic analogue of GHRH(1-29), this research compound features amino acid substitutions at positions 2, 8, 15, and 27, with additional DAC modification for prolonged bioactivity in preclinical models. Euro-Pharmacies supplies this 2mg peptide formulation to Stroid UK Shop investigating growth hormone axis mechanisms and GHRH receptor pharmacology.
Laboratory Research Applications
Research institutions examine CJC-1295 with DAC for its sustained GHRH receptor binding properties compared to endogenous GHRH. Studies investigate the compound’s extended pharmacokinetic profile, with DAC modification enabling reduced dosing frequency in animal models. Researchers analyse its selective interaction with GHRH receptors in hypothalamic-pituitary axis studies, examining pulsatile growth hormone secretion patterns. Academic laboratories exploring peptide research compounds utilise this analogue for comparative studies with unmodified CJC-1295 variants. The compound serves as a valuable tool for investigating peptide stability, bioavailability, and receptor kinetics in endocrine research protocols. Scientists also examine the DAC technology’s influence on peptide distribution and clearance mechanisms in various tissue compartments.
Product Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | Modified GHRH(1-29) with Drug Affinity Complex |
| Purity | ≥98% (HPLC verified) |
| Molecular Weight | Verify with supplier |
| CAS Number | Verify with supplier |
| Formulation | Lyophilised powder |
| Storage | -20°C, protected from light |
| Solubility | Water, bacteriostatic water |
| Manufacturer | Euro-Pharmacies |
Researchers studying CJC-1295 peptide variants can compare this DAC-modified version with other growth hormone secretagogues. Laboratory protocols require appropriate reconstitution with sterile water before analytical procedures. Storage requirements maintain peptide integrity for extended research timelines, while HPLC verification ensures consistent analytical results across experimental protocols. Scientists conducting comparative studies with selective androgen receptor modulators often incorporate this peptide as a growth hormone pathway reference compound.
Research Use Compliance
This CJC-1295 with DAC 2mg peptide is manufactured exclusively for in-vitro research and laboratory analysis purposes. Not intended for human consumption, therapeutic use, or any application outside controlled scientific environments. Researchers must comply with institutional guidelines and appropriate safety protocols when handling this research chemical.
